Clinical Trials Related to Lymphoplasmacytic Lymphoma

Related studies linked through entity extraction aliases.

Imexon for Relapsed Follicular and Aggressive Lymphomas

Status: COMPLETED
Phase: PHASE2

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

Status: COMPLETED
Phase: PHASE2

Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Status: WITHDRAWN
Phase: PHASE1/PHASE2

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

Status: RECRUITING
Phase: N/A

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

Status: COMPLETED
Phase: PHASE3

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Status: COMPLETED
Phase: PHASE2

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

Status: COMPLETED
Phase: PHASE3

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

Status: COMPLETED
Phase: PHASE2

Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia

Status: COMPLETED
Phase: PHASE2

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Status: COMPLETED
Phase: PHASE2